✦ LIBER ✦

Improving quality of care: clinical reasoning for and experiences with patient management of oral anticoagulation

✍ Scribed by Angelika Bernardo; Artur Bernardo; Carola Halhuber

Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 63 KB
Volume: 23
Category: Article
ISSN: 0738-3991
DOI: 10.1016/0738-3991(94)90281-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Quality of integrated care for patients

Quality of integrated care for patients with head and neck cancer: Development and measurement of clinical indicators

✍ Mariëlle M. M. T. J. Ouwens; Henri A. M. Marres; Rosella R. P. Hermens; Marlies 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 2 views

## Abstract ## Background. To improve the quality of integrated care, we developed indicators for assessing current practice in a large reference center for head and neck oncology. ## Methods. We defined a set of indicators based on integrated care literature, national evidence‐based guidelines

Using computers in the practice of medic

Using computers in the practice of medicine: Professional and clinical guidelines for managing your practice and improving patient care

✍ Morton Solomon 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 2 views

Quality of life concerns in patients wit

Quality of life concerns in patients with breast cancer : Evidence for disparity of outcomes and experiences in pain management and palliative care among African-American women

✍ Richard Payne; Eduardo Medina; James W. Hampton 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

## Background: African-american women are at higher risk for breast cancer mortality compared with their white counterparts. furthermore, african-american women present for diagnosis and treatment later in the disease process. it may be expected that this greater disease burden would impose more sy

Usage of erythropoiesis-stimulating agen

Usage of erythropoiesis-stimulating agents in cancer patients at an academic cancer center and experience with specific care management tools for anemia

✍ Alessandra Ferrajoli; Aman U. Buzdar; Yvette DeJesus; Lee Cheng; Laura B. Michau 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 627 KB

## Abstract ## BACKGROUND: In 2007, the US Food and Drug Administration (FDA) issued regulatory alerts for use of erythropoiesis‐stimulating agents (ESAs) in cancer patients with anemia after clinical trials and meta‐analysis data found that high ESA doses were associated with adverse outcomes in